Total Payments
$942.38
2024 Payments
$91.53
Companies
10
Transactions
66
Medicare Patients
1,657
Medicare Billing
$124,233
Payment Breakdown by Category
Food & Beverage$942.38 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $942.38 | 66 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $476.04 | 34 | $0 (2024) |
| Astellas Pharma US Inc | $205.99 | 14 | $0 (2019) |
| GlaxoSmithKline, LLC. | $60.99 | 5 | $0 (2023) |
| PFIZER INC. | $60.08 | 4 | $0 (2019) |
| Sumitomo Pharma America, Inc. | $44.19 | 3 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $27.92 | 2 | $0 (2020) |
| Amarin Pharma Inc. | $19.55 | 1 | $0 (2019) |
| iRhythm Technologies, Inc. | $18.76 | 1 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $16.96 | 1 | $0 (2018) |
| Allergan Inc. | $11.90 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $91.53 | 5 | ABBVIE INC. ($58.46) |
| 2023 | $183.20 | 13 | ABBVIE INC. ($139.53) |
| 2022 | $147.67 | 12 | ABBVIE INC. ($135.46) |
| 2021 | $154.99 | 11 | AbbVie Inc. ($142.59) |
| 2020 | $14.02 | 1 | Teva Pharmaceuticals USA, Inc. ($14.02) |
| 2019 | $132.52 | 9 | Astellas Pharma US Inc ($48.75) |
| 2018 | $92.11 | 6 | Astellas Pharma US Inc ($62.68) |
| 2017 | $126.34 | 9 | Astellas Pharma US Inc ($94.56) |
All Payment Transactions
66 individual payment records from CMS Open Payments — Page 2 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/28/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: NEUROSCIENCE | ||||||
| 05/02/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: NEUROSCIENCE | ||||||
| 03/14/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: NEUROSCIENCE | ||||||
| 02/22/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: NEUROSCIENCE | ||||||
| 01/20/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: NEUROSCIENCE | ||||||
| 12/22/2021 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $12.14 | General |
| Category: NEUROSCIENCE | ||||||
| 10/25/2021 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: NEUROSCIENCE | ||||||
| 09/28/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: NEUROSCIENCE | ||||||
| 09/14/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.29 | General |
| Category: NEUROSCIENCE | ||||||
| 07/29/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: NEUROSCIENCE | ||||||
| 07/28/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: NEUROSCIENCE | ||||||
| 07/23/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.40 | General |
| Category: RESPIRATORY | ||||||
| 05/12/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.79 | General |
| Category: NEUROSCIENCE | ||||||
| 03/02/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.36 | General |
| Category: NEUROSCIENCE | ||||||
| 01/26/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.51 | General |
| Category: NEUROSCIENCE | ||||||
| 01/07/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: NEUROSCIENCE | ||||||
| 05/11/2020 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: Central Nervous System | ||||||
| 09/18/2019 | Teva Pharmaceuticals USA, Inc. | AJOVY (Drug) | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: Central Nervous System | ||||||
| 06/25/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.90 | General |
| Category: NEUROSCIENCE | ||||||
| 06/12/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: UROLOGY | ||||||
| 04/19/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), ANORO | Food and Beverage | In-kind items and services | $10.84 | General |
| Category: RESPIRATORY | ||||||
| 04/02/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $15.49 | General |
| Category: UROLOGY | ||||||
| 02/06/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $19.55 | General |
| Category: Hypertriglyceridemia | ||||||
| 02/05/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: UROLOGY | ||||||
| 01/28/2019 | PFIZER INC. | PREVNAR - 13 (Biological) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: VACCINES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 349 | 446 | $66,033 | $40,114 |
| 2022 | 8 | 306 | 399 | $48,664 | $27,778 |
| 2021 | 9 | 451 | 573 | $59,227 | $27,922 |
| 2020 | 11 | 551 | 684 | $65,896 | $28,419 |
Total Patients
1,657
Total Services
2,102
Medicare Billing
$124,233
Procedure Codes
38
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 100 | 190 | $29,070 | $15,680 | 53.9% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 30 | 30 | $11,910 | $8,180 | 68.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 57 | 57 | $9,006 | $6,861 | 76.2% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 16 | 17 | $5,661 | $3,406 | 60.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 38 | 42 | $4,410 | $2,197 | 49.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 26 | 26 | $2,704 | $1,870 | 69.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 29 | 29 | $1,363 | $851.44 | 62.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 27 | 27 | $1,269 | $792.72 | 62.5% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 13 | 13 | $325.00 | $224.12 | 69.0% |
| 81002 | Urinalysis, manual test | Office | 2023 | 13 | 15 | $315.00 | $51.15 | 16.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 97 | 175 | $26,775 | $13,639 | 50.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 55 | 55 | $8,690 | $6,786 | 78.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 48 | 63 | $6,615 | $3,278 | 49.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 28 | 28 | $2,912 | $1,919 | 65.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 31 | 31 | $1,457 | $866.45 | 59.5% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 13 | 13 | $1,365 | $721.16 | 52.8% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 21 | 21 | $525.00 | $357.44 | 68.1% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 13 | 13 | $325.00 | $210.96 | 64.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 92 | 184 | $28,152 | $9,273 | 32.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 73 | 73 | $11,534 | $9,264 | 80.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 50 | 76 | $7,980 | $2,816 | 35.3% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 33 | 33 | $3,432 | $2,154 | 62.8% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2021 | 85 | 85 | $2,125 | $1,478 | 69.6% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 20 | 24 | $2,520 | $1,287 | 51.1% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 51 | 51 | $1,275 | $890.50 | 69.8% |
About Dr. Jill Parrish, M.D
Dr. Jill Parrish, M.D is a Family Medicine healthcare provider based in Louisville, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1306883186.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jill Parrish, M.D has received a total of $942.38 in payments from pharmaceutical and medical device companies, with $91.53 received in 2024. These payments were reported across 66 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($942.38).
As a Medicare-enrolled provider, Parrish has provided services to 1,657 Medicare beneficiaries, totaling 2,102 services with total Medicare billing of $124,233. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Louisville, OH
- Active Since 06/01/2006
- Last Updated 11/07/2025
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1306883186
Products in Payments
- QULIPTA (Drug) $183.86
- VRAYLAR (Drug) $159.98
- UBRELVY (Drug) $144.10
- Myrbetriq (Drug) $94.56
- MYRBETRIQ (Drug) $79.73
- TRELEGY ELLIPTA (Drug) $60.99
- PREVNAR - 13 (Biological) $60.08
- GEMTESA (Drug) $44.19
- VESICARE (Drug) $31.70
- Vascepa (Drug) $19.55
- ZIO XT Patch (Device) $18.76
- PRADAXA (Drug) $16.96
- AJOVY (Biological) $14.02
- AJOVY (Drug) $13.90
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Louisville
Christopher Rhyne, M.d, M.D
Family Medicine — Payments: $701,120
Family Medicine $701,120
Dr. Suraj Gathani, M.d, M.D
Family Medicine — Payments: $64,592
Family Medicine $64,592
Michael Pendleton, Md, MD
Family Medicine — Payments: $29,425
Family Medicine $29,425
Mandy Whitt, M.d, M.D
Family Medicine — Payments: $23,888
Family Medicine $23,888
Dr. James Wright, M.d, M.D
Family Medicine — Payments: $21,045
Family Medicine $21,045
Rosenberg Reyes, M.d, M.D
Family Medicine — Payments: $18,853
Family Medicine $18,853